Online citations, reference lists, and bibliographies.
← Back to Search

Combined Chemo-magnetic Field-photothermal Breast Cancer Therapy Based On Porous Magnetite Nanospheres

Majid Sharifi, Anwarul Hasan, Nadir Mustafa Qadir Nanakali, Abbas Salihi, F. A. Qadir, H. A. Muhammad, Mudhir Shekha, Falah Mohammad Aziz, Karwan M. Amen, Farrokh Najafi, Hasan Yousefi-Manesh, M. Falahati
Published 2020 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The efficacy of different modalities of treating breast cancer is inhibited by several limitations such as off-targeted drug distribution, rapid drug clearance, and drug resistance. To overcome these limitations, we developed Lf-Doxo-PMNSs for combined chemo-MF-PTT. The PMNSs were synthesized by hydrothermal method and their physicochemical properties were examined by FE-SEM, TEM, DLS, TGA, XRD investigations. The cytotoxicity of as-synthesized NPs against 4T1 cells was carried out by MTT and flow cytometry assays. Afterwards, the anti-cancer activities of as-synthesized Lf-Doxo-PMNSs on the tumor status, drug distribution and apoptosis mechanism were evaluated. The anti-cancer assays showed that Lf-Doxo-PMNSs significantly suppressed the cancer cell proliferation and tumor weight by prolonging drug availability and potential drug loading in tumor cells; whereas they showed a minimum cytotoxicity against non-cancerous cells. Likewise, combined chemo-MF-PTT using Lf-Doxo-PMNSs displayed the highest anti-cancer activity followed by combined chemo-PTT and combined chemo-MF therapy based on altering the apoptosis mechanism. Therefore, these results showed that combined chemo-MF-PTT based on Lf-Doxo-PMNSs can be used as a promising therapeutic platform with potential targeted drug delivery and high loading capacity features as well as reducing cancer drug resistance.
This paper references
10.1021/ACSANM.7B00176
PEGylated Polydopamine Nanoparticles Incorporated with Indocyanine Green and Doxorubicin for Magnetically Guided Multimodal Cancer Therapy Triggered by Near-Infrared Light
Lihong Sun (2017)
10.1021/am1012358
Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.
S. Xuan (2011)
10.1016/j.msec.2016.09.052
Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Yinping Huang (2017)
Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Surface Engineering, Cytotoxicity and Biomedical Applications
M. Mahmoudi (2011)
10.1016/J.APMT.2018.11.008
Magnetic iron oxide nanoparticles/10-hydroxy camptothecin co-loaded nanogel for enhanced photothermal-chemo therapy
Wenting Li (2019)
10.7150/thno.12843
Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy
Yu-Lin Su (2015)
10.1080/07391102.2019.1650114
Fabrication and evaluation of anti-cancer efficacy of lactoferrin-coated maghemite and magnetite nanoparticles
Majid Sharifi (2019)
10.1016/j.jconrel.2019.08.032
Plasmonic gold nanoparticles: Optical manipulation, imaging, drug delivery and therapy.
Majid Sharifi (2019)
10.1016/j.jconrel.2019.02.007
Involvement of planned cell death of necroptosis in cancer treatment by nanomaterials: Recent advances and future perspectives
Majid Sharifi (2019)
10.1016/j.nano.2018.01.005
Doxorubicin-loaded dendritic-Fe3O4 supramolecular nanoparticles for magnetic drug targeting and tumor regression in spheroid murine melanoma model.
Saumya Nigam (2018)
Regulations and Ethical Considerations in Animal Experiments: International Laws and Islamic Perspectives
M. Naderi (2012)
10.3390/nu11102350
Lactoferrin in Human Milk of Prolonged Lactation
Matylda Czosnykowska-Łukacka (2019)
10.1002/chem.201602956
Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
F. Benyettou (2016)
10.1002/smll.201803703
Holo-Lactoferrin Modified Liposome for Relieving Tumor Hypoxia and Enhancing Radiochemotherapy of Cancer.
Z. Zhang (2019)
Proposing a National Ethical Framework for Animal Research in Iran
M. Mobasher (2008)
10.1111/j.2042-7158.2012.01567.x
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar (2013)
10.1038/s41598-017-05461-3
Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line
Marzieh Azizi (2017)
10.1002/jcp.27019
Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool
L. Gholami (2019)
10.1038/s41598-019-39036-1
Chlorin e6-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters as a Theranostic Agent for Dual-Mode Imaging and Photodynamic Therapy
A. Amirshaghaghi (2019)
10.3390/ph9040061
Lactoferrin from Milk: Nutraceutical and Pharmacological Properties
F. Giansanti (2016)
10.1016/j.ejpb.2010.04.017
Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
Wei Zhang (2010)
10.1016/j.talanta.2020.120782
Plasmonic and chiroplasmonic nanobiosensors based on gold nanoparticles.
Majid Sharifi (2020)
10.1016/j.biomaterials.2014.10.064
Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation.
S. Shen (2015)
10.1016/j.drudis.2019.01.006
Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases.
A. Tomitaka (2019)
10.1039/c7bm00999b
Therapeutic applications of iron oxide based nanoparticles in cancer: basic concepts and recent advances.
Madiha Saeed (2018)
10.1016/j.actbio.2019.11.027
Targeting Strategies for SuperParamagnetic Iron Oxide Nanoparticles in Cancer Therapy.
Defu Zhi (2019)
10.1038/s41598-018-19628-z
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
Qiyi Feng (2018)
10.2147/IJN.S94139
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy
Po-Chin Liang (2016)
10.1021/acsnano.5b07249
Duality of Iron Oxide Nanoparticles in Cancer Therapy: Amplification of Heating Efficiency by Magnetic Hyperthermia and Photothermal Bimodal Treatment.
A. Espinosa (2016)
10.1016/j.msec.2017.03.309
Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery.
Mengmeng Song (2017)
10.1016/J.IDAIRYJ.2014.08.016
In vitro evaluation of bovine lactoferrin potential as an anticancer agent
Yunlei Zhang (2015)
10.1158/0008-5472.CAN-12-2796
Acidity generated by the tumor microenvironment drives local invasion.
V. Estrella (2013)
10.18632/oncotarget.8553
Engineered nanoparticles induce cell apoptosis: potential for cancer therapy
Dandan Ma (2016)
10.1002/chem.201504685
Controllable Synthesis of Mesoporous Iron Oxide Nanoparticle Assemblies for Chemoselective Catalytic Reduction of Nitroarenes.
Ioannis T. Papadas (2016)
10.1039/C7TB03206D
AMF responsive DOX-loaded magnetic microspheres: transmembrane drug release mechanism and multimodality postsurgical treatment of breast cancer.
W. Xue (2018)
10.1016/j.pathophys.2015.04.002
Effect of olive leaf extract treatment on doxorubicin-induced cardiac, hepatic and renal toxicity in rats.
A. Kumral (2015)
10.1016/j.bbagen.2019.02.012
A health concern regarding the protein corona, aggregation and disaggregation
M. Falahati (2019)
10.1002/jemt.22251
Mesoporous iron oxide nanoparticles prepared by polyacrylic acid etching and their application in gene delivery to mesenchymal stem cells
Binrui Cao (2013)
10.1038/nnano.2016.168
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.
S. Zanganeh (2016)
10.2217/nnm.15.199
Multimodal iron oxide (Fe3O4)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER(-)/PR(-)/HER2(-)).
J. Kanwar (2016)
10.1016/j.bbagen.2019.129435
Gold nanomaterials as key suppliers in biological and chemical sensing, catalysis, and medicine.
M. Falahati (2019)
10.1038/s41598-017-16962-6
Efficiency of novel nanocombinations of bovine milk proteins (lactoperoxidase and lactoferrin) for combating different human cancer cell lines
Marwa M. Abu-Serie (2017)
10.2147/IJN.S121249
Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy
Rui-meng Yang (2017)
10.1016/j.ejpb.2013.06.015
In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Yanzuo Chen (2013)
10.2147/IJN.S187886
Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models
S. Lugert (2019)
10.1166/jnn.2020.17311
Transferrin-Conjugated Superparamagnetic Iron Oxide Nanoparticles as In Vivo Magnetic Resonance Imaging Contrast Agents.
J. Wang (2020)
10.2147/IJN.S147464
Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment
C. Pan (2018)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar